Neus Basté
Grupo de investigación
- Genómica traslacional y terapias dirigidas en tumores sólidos Pre-doctoral researcher (R1)
Publicaciones destacadas
-
Emerging systemic antitarget treatment for differentiated thyroid carcinoma
Autores:Referencia: Current Opinion In Oncology 2021. -
Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial
Autores:Referencia: Clinical & Translational Oncology 2021. -
Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker
Autores:Referencia: Cancers 2021. -
Immunotherapy combinations for the treatment of patients with solid tumors
Autores:Referencia: Future Oncology 2020. -
Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma
Autores:Referencia: Head And Neck-Journal For The Sciences And Specialties Of The Head And Neck 2020. -
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Autores:Referencia: Lancet 2019. -
New approaches in salivary gland carcinoma
Autores:Referencia: Current Opinion In Oncology 2019. -
Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
Autores:Referencia: European Journal Of Cancer 2019. -
SEOM clinical guidelines for the treatment of head and neck cancer (2017)
Autores:Referencia: Clinical & Translational Oncology 2018. -
Comparison of Treatment Recommendations by Molecular Tumor Boards Worldwide
Autores:Referencia: Jco Precision Oncology 2018.